INTRODUCTION
Heavy metal exposure has long been known to be toxic to humans and animals, causing diseases and occasionally death (Yucesoy et al., 1997b) . Many studies have addressed the toxic effects of heavy metals on specific organism(s) (Fischer and Skreb, 2001 ); other studies have documented the direct immunotoxicity caused by short-term exposure to heavy metals (Marth et al., 2001) ; still others observed genotoxic (Karakaya et al., 2005) , apoptotic effects (de la Fuente et al., 2002) , or even chronic effects resulting from long-term exposure (Koller and Roan, 1977) . There is growing concern about the subtle health effects of lead, cadmium, and mercury. Lead has been used in the past as an additive in gasoline and eventually became widely dispersed throughout the environment. However, since the replacement of leaded gasoline with unleaded gasoline in many countries in the mid-1980s, lead exposure from that source has virtually disappeared (RAMP, 1996; Ransom et al., 1987) . This has led to a welcome decrease in the median blood lead concentration (Rogan and Ware, 2003) .
Indeed, the last decade was particularly fruitful in providing new information on the manifold toxic influences of lead (Lidsky and Schneider, 2003) . However, reviewing these studies has revealed some inconsistency. For example, some publications reported that immunomodulatory effects could be found neither in vitro nor in vivo, even when very high doses were applied (Borella et al., 1990; Yucesoy et al., 1997a) . Most investigators, however, have concluded that an effect exists. In vitro investigations employing human peripheral blood mononuclear cells (PBMC) or T cell clones (McCabe and Lawrence, 1991) , as well as in vivo studies using wild-type (Gupta et al., 2002; Heo et al., 1996; Kim and Lawrence, 2000; McCabe et al., 1999; Miller et al., 1998) or transgenic animals (Heo et al., 1998) , have documented direct, although sometimes contradictory, effects of lead exposure on cytokine profiles or T H cell differentiation.
The differentiation of naïve cell responses into T H 1 or T H 2 branches determines (1) resistance or susceptibility of hosts to infection, (2) development of allergic reactions, and (3) the degree of tissue damage that occurs in many autoimmune diseases (Abbas et al., 1996; Singh et al., 1999) . The balance between allergy-promoting T H 2 cells and infection-fighting T H 1 cells is considered to be a critical component of the immune system. Hitherto, many reports have addressed the effects of lead on the T H 1-T H 2 cell balance, but again some showed contradictory results. The seminal work in this area is that of McCabe and Lawrence (1991) who found, through the employment of antigen-specific T cell clones, that exposure to lead resulted in a T H 2 activation preference. Corroborating these findings, Yucesoy et al. (1997b) found that T H 1 cytokines were reduced in workers occupationally exposed to lead, although this skewing occurred only in the presence of antigens. In contrast, preferential production of T H 1 cytokines as a result of lead exposure was reported by Krocova et al. (2000) .
The current increase in disease susceptibility in polluted areas implicates the environment and demonstrates the necessity for further studies to reveal the effects this pollutant may have and the mechanisms involved. Cytokine profiles can be differentially affected by heavy metals at concentrations that do not affect other arms of the immune system (Shen et al., 2001) . Therefore, examining cytokine changes may offer a more sensitive analysis of risk to human health than direct observation of other immune parameters. This study attempts to evaluate the in vitro immunomodulatory activities of lead, and especially its effects on T H 1-T H 2 homeostasis as observed from changes in cytokine profiles. Two forms of lead salts and two stimulation protocols were applied.
MATERIALS AND METHODS
Cell culture. Peripheral blood mononuclear cells were separated from buffy coats of healthy donors using Ficoll-density gradient (Amersham Biosciences, Uppsala, Sweden). Buffy coats were obtained from the Blood Bank of the University Clinic of Leipzig, Germany. Isolated cells were suspended in HybridoMed DIF 1000 (Biochrom, Berlin, Germany) and cultured at a density of 1 3 10 6 PBMC/ml in 48-well flat-bottom microtiter plates (Greiner Bio-one GmbH, Nürtingen, Germany). Cells were stimulated either with monoclonal antibodies (mAbs) against CD3 (OKT3, mouse IgG1; Ortho Biotech, Bridgewater, NJ), CD28 (clone CD28.2, mouse IgG1; Immunotech, Marseille, France) and CD40 (clone B-B20, Trinova Biochem, Gieben, Germany), each at a final concentration of 100 ng/ml, or with heatkilled Salmonella enteritidis (hk-SE) at a final concentration of 1.25 3 10 5 colony-forming units (CFU)/ml.
Application of lead salts. Stock solutions of lead acetate (Sigma-Aldrich, Deisenhofen, Germany) and lead chloride (Merck-Schuchardt, Hohenbrunn, Germany) were prepared in deionized water. Immediately before application, 14 serial doses were made using the culture medium: 5.0 mg-1.5 ng and 0.5 mg-0.15 ng/ml for both salts, respectively. As control samples, cells received either media alone (nonstimulated control 1) or mAbs or hk-SE (stimulated control 2).
MTT cell vitality/proliferation test. The method employed is that described by Mosmann (1983) and modified by Wichmann et al. (2002) . After 24 h of exposure to lead, 750 ll of cell-free culture supernatant was harvested. The remaining cells were treated with 25 ll/well MTT solution (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide, 5 g/l phosphate buffered saline (PBS); Sigma, Deisenhofen, Germany) and were incubated in the dark at 37°C. After 4 h, the metabolic conversion of MTT into purple formazan crystals by active cells was terminated by adding 300 ll/well stop solution (10% w/v sodium dodecylsulfate (SDS) in 50% v/v N,N#-dimethylformamide, SERVA, Heidelberg, Germany). After incubation overnight, the MTT assay results were read using an enzyme-linked immunosorbent assay (ELISA)-Reader (Spectra Image; Tecan, Crailsheim, Germany) with a 570-nm filter and a 450-nm reference filter.
Detection of cytokine release by ELISA. The cytokines IL-1b, IL-4, IL-6, IL-10, IFN-c, and TNF-a in culture supernatants were determined using ELISA kits (OptEIAKits; BD Biosciences, Heidelberg, Germany) according to the manufacturer's instructions. 3,3#,5,5#-Tetramethylbenzidine (TMB; Pharmingen, BD Biosciences, Heidelberg, Germany) was used as a substrate. The optical density was measured by ELISA-Reader with a 450-nm filter and a 620-nm reference filter.
Intracellular cytokine staining. Intracellular cytokines were evaluated by flow cytometry as follows: PBMC (2 3 10 6 /ml) were seeded in TPP cell-culture tubes (Techno Plastic Products AG, Trasadingen, Switzerland). After 24 h of exposure to lead at 37°C/5% CO 2, cells received 1.0 ml fresh medium containing 1.0 lM ionomycin (Calbiochem, Bad Soden, Germany), 2.5 lM phorbol-12-myristate 13-acetate (PMA) and 2.5 lM monensin (Sigma Aldrich, Deisenhofen, Germany). After another incubation period of 4 h, cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% saponin, and stained with fluorescein isothiocyanate (FITC)-labeled mAbs against the CD3 (UCHT1), and PE-labeled mAbs against the cytokines IFN-c (45.15) or IL-4 (4D9) (Beckman-Coulter, Krefeld, Germany). Mouse IgG1 PE-labeled isotype control was used. Fluorescence-labeled cells were analyzed by flow cytometer (FACSCalibur, Becton Dickinson, Germany).
Statistical analysis. All experiments were carried out in triplicate. Data analysis was performed with the STATISTICA 5.1 software (Statsoft, Hamburg, Germany) . Differences between control samples and lead-treated cells were tested with the Wilcoxon test for paired samples with an entry criterion of 0.05.
RESULTS

Cell Vitality
Twenty-four-hour exposure to lead doses above 50.0 lg/ml exhibited strong cytotoxic effects ( Fig. 1 ), but lower doses ranging from 15 pg/ml to 50 lg/ml significantly inhibited cell vitality and/or proliferation in a dose-dependent manner. These effects were independent of the kind of cell activators used or the metal salts tested. Similar results were obtained in both cases.
Cytokine Release
Changes in in vitro cytokine release by mAb or hk-SEstimulated human PBMC after short-term exposure to one or both metal forms are represented as percentages of the accompanying controls (Figs. 2 and 3). The normal cytokine ranges of these controls, where cells are stimulated either by mAb or hk-SE, but not by lead, are represented in Table 1 . A dose-dependent stimulation or inhibition of cytokine production resulted from exposure to lead.
As shown in Figure 2 , after exposure to lead acetate, the release of the proinflammatory cytokines TNF-a by mAbsstimulated PBMC was significantly reduced at lead doses above 1.5 ng/ml, IL-1b above 5.0 ng/ml, and IL-6 from 150.0 ng/ml to 15.0 mg/ml. The exception was the stimulation of IL-6 release at doses lower than 150.0 ng/ml. Furthermore, IFN-c release was significantly reduced at all tested doses of lead 2 from 1.5 ng to 5.0 mg/ml. In contrast, secretion of IL-10 and IL-4 was significantly increased at all doses below 150.0 and 15.0 lg/ml, respectively. The production of all cytokines is drastically inhibited at lead doses above 150.0 lg/ml (Figs. 2  and 3 ). Estimating the ratio of %IFN-c/%IL-4 provided a picture of the T H 1-T H 2 balance. Because a balance between the two cell types is hypothesized to exist, a sample was obtained at all tested doses below 150.0 lg/ml (Fig. 2g) ; a value lower than unity for a given sample indicated a probable deviation toward the T H 2 type. Similar results were obtained when comparing the ratios of %IFNc and %IL-10 (Fig. 2h) , which could also indicate a T H 2 polarized immune response at all lead doses tested. With minor differences up to one dilution step, we obtained the same results by applying lead chloride (data not shown).
Cytokine profiles of hk-SE stimulated PBMC after 24 h of exposure to lead acetate and lead chloride were also identical.
After exposure to lead chloride (Fig. 3) , the release of TNF-a and IL-1b at all doses above 150.0 pg/ml and the release of IL-6 at doses above 1.5 ng/ml was significantly inhibited. Exceptions were the significant stimulation of TNF-a and IL-6 release at higher doses, in the range 0.5/ml to 150 lg/ml ( Fig.  3a and 3c ) and IL-6 at lower doses of 150 and 50 pg/ml. IFN-c production by hk-SE-stimulated cells was reduced at all doses; this inhibition was significant at doses from 150 pg/ml to 150 ng/ml. Again, although hk-SE failed to produce detectable levels of IL-4 after exposure to lead chloride, IL-10 release was significantly stimulated at lower doses and inhibited at higher doses (Fig. 3e) . Estimating the ratios %IFN-c/%IL-10 revealed the polarization of the immune response toward IL-10 production; at low doses of 150.0 pg/ml and up to 15.0 ng/ml, a significant decrease in the ratios resulted (Fig. 3f) .
Intracellular Cytokines
Intracellular cytokine staining was carried out to investigate the differentiation preference of T cells by lead. Of the total T lymphocytes, the proportions of IFN-c-producing and IL-4-producing cells were estimated and expressed as percentages of the controls (Fig. 4) . With few exceptions, a dose-dependent decrease in IFN-c-producing CD3 þ T cells was found after lead exposure. In contrast, the number of IL-4-producing T cells increased after exposure to non-toxic doses of lead (from 150.0 pg/ml to 15.0 ng/ml); it then decreased with the increase in lead toxicity (at doses higher than 15.0 lg/ml). Estimating the %IFN-c/%IL-4 ratio could clearly represent the preferential proliferation of IL-4-producing T cells in comparison to IFNc-producing cells (Fig. 4c) . A decrease in the ratio resulted at all tested doses, except at 15.0 ng/ml and 150.0 lg/ml, where about 90% of the tested samples showed a polarized T H 2 response, reflected by the increase in the percentage of IL-4-producing T cells.
DISCUSSION
Heavy metals may influence cells by penetrating the interior of the cell through calcium channels and/or by reacting with surface structures of the cell, such as the cell receptors or associated ligands (Kerper and Hinkle, 1997; Marth et al., 2001) . The hypothesis tested here is whether lead promotes T H 2-dependent response over T H 1 response, which may contribute to the increased incidence of atopy and allergic diseases in polluted areas.
Lead Reduces Cell Vitality and/or Proliferation
One of the mechanisms by which lead and other heavy metals can affect the immune system, is through effects on cell vitality and proliferation. Our results demonstrate an inhibitory effect of lead on the vitality and/or proliferation of human PBMC. However, previous investigations showed conflicting results. It was found in some studies that lead did not affect cell vitality or growth (Borella et al., 1990; Smith and Lawrence, 1988) , whereas inhibitory or stimulatory effects of lead on immune competent cells were described in other reports. For example, a significant inhibitory effect of lead on rat splenocytes derived from rats exposed to 10 or 1000 lg/ml lead was demonstrated by Exon et al. (1985) . Similarly, lead was found to enhance B cell proliferation (Lawrence, 1981) and T cell proliferation (Warner and Lawrence, 1986) in mice. Tellingly, lead augmented the proliferation of rat spleen cells at doses of 0.5 to 200 lg/ml, but it inhibited proliferation at doses above 200 lg/ml (Razani-Boroujerdi et al., 1999) . These data provide a reason for the contradictory results: conflicting findings may be attributed to differences in lead doses or in the experimental models used. Our results confirm that exposure to lower as well as higher lead doses, namely, from 150 pg/ml up to 5 mg/ml, significantly inhibits cell vitality and/or proliferation. We propose that the capability of lead to impair cell vitality may 
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be the result of (1) the direct interaction between the lead ion and mAbs or hk-SE, and/or (2) interference with cell metabolism.
Lead Exerts a Differential Effect on T H 1-T H 2 Balance
The mechanisms by which lead affects the T H 1-T H 2 balance may include some or all of the following: (1) direct inhibition of T H 1 cells by lead; (2) stimulation of T H 2 cell activities, which induce cytokine release, which in turn inhibits T H 1 cell activity; and (3) an indirect inhibition of T H 1 cells mediated by impairment of antigen-presenting cells (APC). In light of previous investigations (e.g., McCabe et al., 1999; Shen et al., 2001) , and as demonstrated here, it seems that the most rational approach to revealing the cellular interactions involved would be to measure cytokine profile changes. We found that shortterm exposure of PBMC to low lead doses had immunomodulatory effects that might reflect skewness of the immune response toward the T H 2 type.
In mAbs-activated cells, a significant increase in IL-4, IL-10, and IL-6 release occurred after exposure to lead acetate or lead chloride. Production of the T H 1 cytokine IFN-c and of the proinflammatory cytokines TNF-a and IL-1b was significantly inhibited. Slightly different results were obtained from hk-SEstimulated cells. These included stimulation of TNF-a and IL-6 release at higher lead doses, the undetectable production of IL-4, and the relative increase in IFN-c production, which is evident by comparing the IFN-c/IL-10 ratios between the two models of cell stimulation. Therefore, we suggest that different lead immunomodulatory pathways become active according to the microenvironment of cell stimulation.
Evaluating the intracellular cytokines could also reveal the proliferation preference of T H 2 cells at lower lead doses. Therefore, suppression of the IFN-c release, together with the stimulation of IL-4 and/or IL-10 release indicated by ELISA, may be due to a reduction in the number of IFN-c-producing cells and preferential proliferation of IL-4-producing and/or IL-10-producing cells (T H 2 cells), or by changing cytokine production potency of both T H cell subsets.
Some previous investigations reported no influence of lead on the immune response (Blakley et al., 1982; Yucesoy et al., 1997a) . Our results, however, are in agreement with other data 6 documenting an inclination toward T H 2 immune response following exposure to lead. In direct opposition to these data, Guo et al. (1996) and Krocova et al. (2000) found a preferential production of T H 1 cytokines; TNF-a was produced by macrophages as well as by T cells. Our assertion that high lead doses stimulate TNF-a production by hk-SE-stimulated cells confirms the studies of Guo et al. (1996) and indicates a relative increase in the activity of hk-SE stimulated macrophages at high lead doses. The dissimilarity in reactivity of IFN-c and TNF-a may result from the differing methods or crossregulatory processes from other segments of the immune system that are compromised in our models. But, the finding that IL-10 inhibits cytokine production by T H 1 cells (Mosmann and Moore, 1991) and the reciprocal regulation of T H 1 and T H 2 cells (Dubey et al., 1991; Manetti et al., 1993) rather confirms our results concerning the inhibition of IFN-c and TNF-a levels and the preferential proliferation of T H 2 in association with lower nontoxic doses of lead.
The Role of IL-4, -6, and -10 in Lead-Induced Immunomodulation
The preferential stimulation of T H 2 immune response by lead is suggested here by the increase in IL-4, IL-6, and IL-10 production observed after exposure to lead. Indeed, many investigations have addressed IL-4 as the major determinant for differentiation of antigen-stimulated naive T cells into T H 2 cells (Le Gros et al., 1990) . The importance of IL-10 in the T H 1-T H 2 immune balance, however, has long been debated. Although IL-10 has been reported to be secreted by both CD4 þ subsets (Yssel et al., 1992) , the finding that IL-10 inhibits cytokine production by T H 1 cells (Fiorentino et al., 1989; Mosmann and Moore, 1991) would support its role in inducing T H 2 immune responses. Thus, it is reasonable here to suggest a skewed T H 2 immune response after lead exposure, even in the absence of detectable levels of IL-4 in the hk-SE-stimulation model. Therefore, not all cytokines are indicative of impairment in T H cell balance and, in some instances, cytokine levels could be misleading. Mihara et al. (1991) found that IL-6 inhibited delayed-type hypersensitivity reactions that are known to be elicited by T H 1 responses. Therefore, the elevated IL-6 levels may be a further indication of a T H 2-polarized response, which suggests a heightened stress based on the absence of a priming level of IFN-c.
In asthma, T H 1 type reactions are deficient and T H 2 reactions predominate. T H 2 reactions are driven by IL-4, IL-5, IL-10, and IL-13 and result in an increase in IgE production. Indeed, significantly elevated levels of IgE have been found in leadexposed workers, although no significant relationship between blood lead levels and serum IL-4 or IFN-c levels was observed (Heo et al., 2004) . The range of lower doses of lead used in our study is comparable to the blood lead levels found in workers occupationally exposed to lead-range: 0.07 to >0.8 lg/ml (Basaran and Undeger, 2000; Heo et al., 2004; Palus et al., 2003; Sata et al., 1998; Stollery et al., 1991; Truckenbrodt et al., 1984) . Thus, the lower T H 1:T H 2 ratio we obtained confirms some previous reports of immunomodulation by lead and raises the possibility for the development of allergic and/or autoimmune diseases as suggested by Heo et al. (1996) .
Lead Reduces the Proinflammatory Response
Exposure to lead resulted in a significant inhibition in the production of the proinflammatory cytokines TNF-a and IL1b, which are mediators of the inflammatory response and which are released from different cell types (Schuerwegh et al., 2003) . The importance of IL-1b, a primary mediator of immune response to injury and infection (Brough et al., 2003) , and TNF-a in immune response stems largely from their ability to promote T H 1 versus T H 2 pathways by antigen presenting cells (APC; Cervi et al., 2004) . These cytokines increase the efficiency with which an APC can bind and activate T H cells. It seems then, that lead exerts an inhibitory effect on APC, leading to the inhibition of TNF-a and IL-1b release and consequently to clonal proliferation.
Overall, we conclude that lead skews the immune response toward the T H 2 pathway, leading to a weakened ability of the body to defend against various infections and an enhanced risk of allergic diseases. The use of two forms of the metal confirms the hypothesis that it is the action of the metal ion that is operative, regardless of the applied form. This was not the case when applying two models of immune stimulation; both revealed identical effects, but they demonstrated that lead may act through different pathways including different cytokine mediators. Identification of the intermediate molecules, as well as the mechanisms that establish such susceptibility or the initiation of the T H 1-T H 2 imbalance, may be an important goal for future experiments.
